Continuous renal replacement therapy

International Anesthesiology Clinics

Volumn 39, Issue 1, 2001, Pages 111-125

  Brush, K A ^a   Bilodeau, M L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MEDICAL ETHICS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; TREATMENT INDICATION; VASCULAR ACCESS;

EID: 0035102467     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-200101000-00010     Document Type: Review

References (34)

1. Continuous renal replacement therapies: An update
2. Continuous venovenous hemodiafiltration compared with conventional dialysis in critically ill patients with acute renal failure
3. Continuous renal replacement therapy compared with intermittent hemodialysis in intensive care: Which is better?
4. Continuous versus intermittent renal replacement therapy in the intensive care unit
5. Continuous versus intermittent renal replacement therapy in the treatment of acute renal failure
6. Comparing continuous hemofiltration with hemodialysis in patients with acute renal failure
7. CAVH: Principles and practical applications
8. Adult/pediatric CVVH: The pump, the patient, the circuit
9. Selection of patients for continuous renal replacement therapy
10. Fever in the critical care unit
11. Practice parameters for evaluating new fever in critically ill adult patients
12. The evaluation of fever in the intensive care unit
13. Fever in the intensive care unit
14. Intravascular-related-catheter infections
15. Heparin-induced thrombocytopenia
16. Hemofilter clotting in ICU patients may be related to low antithrombin III levels rather than heparin clearance
17. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients
18. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding
19. Anticoagulation in continuous extracorporeal renal replacement therapy
20. Continuous venous to venous hemofiltration: Implementing and maintaining a program: Examples and alternatives
21. Acute renal failure and dialysis
22. Hemodialysis membrane bioincompatibility in acute renal failure
23. Pharmacokinetics of continuous renal replacement therapy
24. Management of drug dosing in continuous renal replacement therapy
25. Drug dosing in acute renal failure: The role of renal replacement therapy in altering drug pharmacokinetics
26. Drug dosing adjustments during continuous renal replacement therapy
27. Individualized drug dosage in patients treated with continuous hemofiltration
28. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration
29. Cytokine removal during continuous hemofiltration in septic patients
30. Fluid management in continuous renal replacement therapy
31. Acid-base balance in continuous renal replacement therapy
32. To dialyze or not to dialyze: An ethical and evidence-based approach to the patient with acute renal failure in the intensive care unit
33. Bioethical issues related to continuous renal replacement therapy in intensive care patients
34. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration